Literature DB >> 23019238

Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.

Kirsten Egebjerg Jensen1, Sven Schmiedel, Kirsten Frederiksen, Bodil Norrild, Thomas Iftner, Susanne K Kjær.   

Abstract

BACKGROUND: Smoking has been associated with cervical cancer. We examined whether smoking increases the risk for high-grade cervical lesions in women with high-risk human papillomavirus (HPV) infection.
METHODS: In a population-based cohort study, 8,656 women underwent a structured interview, and subsequently cervical cells were obtained for HPV DNA testing. Women with high-risk HPV infection and no prevalent cervical disease at baseline (n = 1,353) were followed through the Pathology Data Bank for cervical lesions for up to 13 years. Separate analyses of women with persistent high-risk HPV infection (n = 312) were also conducted. HRs for a diagnosis of cervical intraepithelial neoplasia grade 3 or worse/high-grade squamous intraepithelial lesions or worse (CIN3+) and the corresponding 95% confidence intervals (CI) were calculated in the two groups.
RESULTS: Among high-risk HPV-positive women, an increased risk for CIN3+ was associated with long-term smoking (≥10 years) and heavy smoking (≥20 cigarettes/d). In the subgroup of women with persistent HPV infection, heavy smoking was also associated with a statistically significantly higher risk for CIN3+ than never smoking (HR, 1.85; 95% CI, 1.05-3.22, adjusted for length of schooling, parity, and HPV type at baseline). The average number of cervical cytology screening tests per year during follow-up did not explain the differences in risk in relation to smoking (P = 0.4).
CONCLUSIONS: Smoking is associated with an increased risk for subsequent high-grade cervical lesions in women with persistent high-risk HPV infection. IMPACT: Our study adds to the understanding of the role of smoking in the natural history of HPV and cervical carcinogenesis. ©2012 AACR

Entities:  

Mesh:

Year:  2012        PMID: 23019238      PMCID: PMC3970163          DOI: 10.1158/1055-9965.EPI-12-0663

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  25 in total

1.  The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period.

Authors:  Susanne Kjaer; Estrid Høgdall; Kirsten Frederiksen; Christian Munk; Adriaan van den Brule; Edith Svare; Chris Meijer; Attilla Lorincz; Thomas Iftner
Journal:  Cancer Res       Date:  2006-10-23       Impact factor: 12.701

2.  Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers.

Authors:  B Prokopczyk; J E Cox; D Hoffmann; S E Waggoner
Journal:  J Natl Cancer Inst       Date:  1997-06-18       Impact factor: 13.506

3.  Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.

Authors:  Susanne K Kjær; Kirsten Frederiksen; Christian Munk; Thomas Iftner
Journal:  J Natl Cancer Inst       Date:  2010-09-14       Impact factor: 13.506

4.  The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis.

Authors:  Samina Alam; Michael J Conway; Horng-Shen Chen; Craig Meyers
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

5.  Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert Burk
Journal:  J Natl Cancer Inst       Date:  2008-03-25       Impact factor: 13.506

Review 6.  Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis.

Authors:  Jill Koshiol; Lisa Lindsay; Jeanne M Pimenta; Charles Poole; David Jenkins; Jennifer S Smith
Journal:  Am J Epidemiol       Date:  2008-05-15       Impact factor: 4.897

7.  Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.

Authors:  Sophia S Wang; Rosemary E Zuna; Nicolas Wentzensen; S Terence Dunn; Mark E Sherman; Michael A Gold; Mark Schiffman; Sholom Wacholder; Richard A Allen; Ingrid Block; Kim Downing; Jose Jeronimo; J Daniel Carreon; Mahboobeh Safaeian; David Brown; Joan L Walker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

Review 8.  Effects of tobacco smoke on immunity, inflammation and autoimmunity.

Authors:  Yoav Arnson; Yehuda Shoenfeld; Howard Amital
Journal:  J Autoimmun       Date:  2009-12-29       Impact factor: 7.094

9.  HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.

Authors:  A Hildesheim; R Herrero; P E Castle; S Wacholder; M C Bratti; M E Sherman; A T Lorincz; R D Burk; J Morales; A C Rodriguez; K Helgesen; M Alfaro; M Hutchinson; I Balmaceda; M Greenberg; M Schiffman
Journal:  Br J Cancer       Date:  2001-05-04       Impact factor: 7.640

10.  Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort.

Authors:  J M Deacon; C D Evans; R Yule; M Desai; W Binns; C Taylor; J Peto
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  14 in total

1.  Smoking cessation advice after cervical screening: a qualitative interview study of acceptability in Dutch primary care.

Authors:  Marthe Bl Mansour; Mathilde R Crone; Henk C van Weert; Niels H Chavannes; Kristel M van Asselt
Journal:  Br J Gen Pract       Date:  2018-12-03       Impact factor: 5.386

2.  Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.

Authors:  Zhanzhan Xu; Yu Zhou; Fang Shi; Yexuan Cao; Thi Lan Anh Dinh; Jing Wan; Min Zhao
Journal:  Oncol Lett       Date:  2017-02-22       Impact factor: 2.967

3.  The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study.

Authors:  Victoria Umutoni; Matthew B Schabath; Alan G Nyitray; Timothy J Wilkin; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano; Staci L Sudenga
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-08-02       Impact factor: 4.090

Review 4.  Importance of adrenergic pathways in women's cancers.

Authors:  Premal H Thaker; Anil K Sood; Lois M Ramondetta
Journal:  Cancer Biomark       Date:  2013       Impact factor: 4.388

5.  Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.

Authors:  Susanne K Kjaer; Christian Dehlendorff; Federica Belmonte; Louise Baandrup
Journal:  J Natl Cancer Inst       Date:  2021-10-01       Impact factor: 13.506

6.  Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up.

Authors:  K E Jensen; S Schmiedel; B Norrild; K Frederiksen; T Iftner; S K Kjaer
Journal:  Br J Cancer       Date:  2012-11-20       Impact factor: 7.640

7.  Smoking cessation strategy in the national cervical cancer screening program (SUCCESS): study protocol for a pragmatic cluster randomised trial and process evaluation in Dutch general practice.

Authors:  Marthe Bl Mansour; Mathilde R Crone; Edanur Sert; Henk C van Weert; Niels H Chavannes; Kristel M van Asselt
Journal:  BMJ Open       Date:  2022-04-04       Impact factor: 2.692

8.  Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-years.

Authors:  Anna Paaso; Hanna-Mari Koskimaa; Marij Jp Welters; Seija Grénman; Kari Syrjänen; Sjoerd H van der Burg; Stina Syrjänen
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

9.  Identification of differentially-expressed genes by DNA methylation in cervical cancer.

Authors:  Heun-Sik Lee; Jun Ho Yun; Junghee Jung; Young Yang; Bong-Jo Kim; Sung-Jong Lee; Joo Hee Yoon; Yong Moon; Jeong-Min Kim; Yong-Il Kwon
Journal:  Oncol Lett       Date:  2015-01-29       Impact factor: 2.967

10.  Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer.

Authors:  Jungnam Joo; Kyong-Ah Yoon; Tomonori Hayashi; Sun-Young Kong; Hye-Jin Shin; Boram Park; Young Min Kim; Sang-Hyun Hwang; Jeongseon Kim; Aesun Shin; Joo-Young Kim
Journal:  Cancer Res Treat       Date:  2015-06-22       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.